Yassine F - Search Results

1

Targeting chronic lymphocytic leukemia with B-cell activating factor receptor CAR T cells.

Qie Y, Gadd ME, Shao Q, To T, Liu A, Li S, Rivera-Valentin R, Yassine F, Murthy HS, Dronca R, Kharfan-Dabaja MA, Qin H, Luo Y. Qie Y, et al. Among authors: yassine f. MedComm (2020). 2024 Sep 2;5(9):e716. doi: 10.1002/mco2.716. eCollection 2024 Sep. MedComm (2020). 2024. PMID: 39224539 Free PMC article.

2

Driving Out Chronic Lymphocytic Leukemia With CAR T Cells.

Kharfan-Dabaja MA, Yassine F, Gadd ME, Qin H. Kharfan-Dabaja MA, et al. Among authors: yassine f. Transplant Cell Ther. 2022 Jan;28(1):5-17. doi: 10.1016/j.jtct.2021.10.005. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656807 Free article. Review.

3

Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.

Luo Y, Qie Y, Gadd ME, Manna A, Rivera-Valentin R, To T, Li S, Yassine F, Murthy HS, Dronca R, Kharfan-Dabaja MA, Qin H. Luo Y, et al. Among authors: yassine f. Cancer Immunol Immunother. 2023 Dec;72(12):4031-4047. doi: 10.1007/s00262-023-03537-w. Epub 2023 Oct 10. Cancer Immunol Immunother. 2023. PMID: 37814001 Free PMC article.

4

Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials.

Yassine F, Iqbal M, Murthy H, Kharfan-Dabaja MA, Chavez JC. Yassine F, et al. Curr Res Transl Med. 2020 Nov;68(4):159-170. doi: 10.1016/j.retram.2020.05.005. Epub 2020 Aug 15. Curr Res Transl Med. 2020. PMID: 32811793 Review.

5

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors.

Yassine F, Reljic T, Moustafa MA, Iqbal M, Murthy HS, Kumar A, Kharfan-Dabaja MA. Yassine F, et al. Hematol Oncol Stem Cell Ther. 2022 Mar 1;15(1):36-43. doi: 10.1016/j.hemonc.2021.02.003. Hematol Oncol Stem Cell Ther. 2022. PMID: 33789163 Free article.

6

Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions.

Chavez JC, Yassine F, Sandoval-Sus J, Kharfan-Dabaja MA. Chavez JC, et al. Among authors: yassine f. Int J Hematol Oncol. 2021 Aug 3;10(2):IJH33. doi: 10.2217/ijh-2020-0021. eCollection 2021 Jun. Int J Hematol Oncol. 2021. PMID: 34540198 Free PMC article. Review.

7

Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma: What is the Evidence?

Kharfan-Dabaja MA, Yassine F, Moustafa MA, Iqbal M, Murthy H. Kharfan-Dabaja MA, et al. Among authors: yassine f. Hematol Oncol Stem Cell Ther. 2022 Dec 23;15(4):168-175. doi: 10.1016/j.hemonc.2021.09.004. Hematol Oncol Stem Cell Ther. 2022. PMID: 34699774 Free article. Review.

8

Management of CAR T-cell Related Toxicities: What did the Learning Curve Teach us so Far?

Murthy HS, Yassine F, Iqbal M, Alotaibi S, Moustafa MA, Kharfan-Dabaja MA. Murthy HS, et al. Among authors: yassine f. Hematol Oncol Stem Cell Ther. 2022 Nov 7;15(3):100-111. doi: 10.56875/2589-0646.1029. Hematol Oncol Stem Cell Ther. 2022. PMID: 36395496 Free article. Review.

9

Understanding the Etiology of Pancytopenias in the CAR T-Cell Therapy Setting: What We Know and What We Don't?

Yassine F, Murthy H, Ghabashi E, Kharfan-Dabaja MA, Iqbal M. Yassine F, et al. Hematol Oncol Stem Cell Ther. 2022 Nov 25;15(3):122-130. doi: 10.56875/2589-0646.1047. Hematol Oncol Stem Cell Ther. 2022. PMID: 36633964 Free article. Review.

10

Cellular Therapies for Mantle Cell Lymphoma.

Yassine F, Sandoval-Sus J, Ayala E, Chavez J, Hamadani M, Kharfan-Dabaja MA. Yassine F, et al. Transplant Cell Ther. 2021 May;27(5):363-370. doi: 10.1016/j.jtct.2021.01.026. Epub 2021 Feb 6. Transplant Cell Ther. 2021. PMID: 33965173 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters